Epigenetic induction of the Ink4a/Arf locus prevents Schwann cell overproliferation during nerve regeneration and after tumorigenic challenge

Brain

Volumn 136, Issue 7, 2013, Pages 2262-2278

  Gomez Sanchez, Jose Antonio ^a,b   Gomis Coloma, Clara ^a,b   Morenilla Palao, Cruz ^a   Peiro, Gloria ^b   Serra, Eduard ^c   Serrano, Manuel ^d   Cabedo, Hugo ^a,b  

^a INSTITUTO DE NEUROCIENCIAS   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^c Institut de Medicina Predictiva i Personalitzada del Cancer IMPPC   (Spain)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

cellular biology; nerve injury; nerve regeneration; neuroscience; Schwann cells

Indexed keywords

BETA TUBULIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; HISTONE DEMETHYLASE; HISTONE H3; MESSENGER RNA;

ARTICLE; CELL AGING; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; ELECTRON MICROSCOPY; EPIGENETICS; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MOUSE; NERVE FIBER; NERVE REGENERATION; NEUROFIBROMA; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SCHWANN CELL; SIGNAL TRANSDUCTION;

EID: 84879922874     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt130     Document Type: Article

References (53)

1. Agger K, Cloos PA, Christensen J, Pasini D, Rose S, Rappsilber J, et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 2007; 449: 731-4
2. Agger K, Cloos PA, Rudkjaer L, Williams K, Andersen G, Christensen J, et al. The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene-And stress-induced senescence. Genes Dev 2009; 23: 1171-6
3. Agherbi H, Gaussmann-Wenger A, Verthuy C, Chasson L, Serrano M, Djabali M. Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence. PLoS One 2009; 4: E5622
4. Ameyar-Zazoua M, Wisniewska MB, Bakiri L, Wagner EF, Yaniv M, Weitzman JB. AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene. Oncogene 2005; 24: 2298-306
5. Arthur-Farraj PJ, Latouche M, Wilton DK, Quintes S, Chabrol E, Banerjee A, et al. c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration. Neuron 2012; 75: 633-47
6. Atanasoski S, Boller D, De Ventura L, Koegel H, Boentert M, Young P, et al. Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferation. Glia 2006; 53: 147-57
7. Atanasoski S, Shumas S, Dickson C, Scherer SS, Suter U. Differential cyclin D1 requirements of proliferating Schwann cells during development and after injury. Mol Cell Neurosci 2001; 18: 581-92
8. Barradas M, Anderton E, Acosta JC, Li S, Banito A, Rodriguez-Niedenfuhr M, et al. Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS. Genes Dev 2009; 23: 1177-82
9. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004; 432: 324-31
10. Binet R, Ythier D, Robles AI, Collado M, Larrieu D, Fonti C, et al. WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway. Cancer Res 2009; 69: 9183-91
11. Birchmeier C, Nave KA. Neuregulin-1, a key axonal signal that drives Schwann cell growth and differentiation. Glia 2008; 56: 1491-7
12. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D, Gargiulo G, Beekman C, et al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 2007; 21: 525-30
13. Brockes JP, Fields KL, Raff MC. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res 1979; 165: 105-18
14. Carroll SL, Ratner N. How does the Schwann cell lineage form tumors in NF1? Glia 2008; 56: 1590-605
15. Carroll SL, Miller ML, Frohnert PW, Kim SS, Corbett JA. Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration. J Neurosci 1997; 17: 1642-59
16. Cichowski K, Shih TS, Schmitt E, Santiago S, Reilly K, McLaughlin ME, et al. Mouse models of tumor development in neurofibromatosis type 1. Science 1999; 286: 2172-6
17. Collado M, Serrano M. Senescence in tumours: Evidence from mice and humans. Nat Rev Cancer 2010; 10: 51-7
18. Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell 2007; 130: 223-33
19. Courtois-Cox S, Genther Williams SM, Reczek EE, Johnson BW, McGillicuddy LT, Johannessen CM, et al. A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 2006; 10: 459-72
20. Dvorak HF. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 1650-9
21. Endo M, Kobayashi C, Setsu N, Takahashi Y, Kohashi K, Yamamoto H, et al. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors. Clin Cancer Res 2011; 17: 3771-82
22. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002; 39: 311-4
23. Fruttiger M, Schachner M, Martini R. Tenascin-C expression during wallerian degeneration in C57BL/Wlds mice: Possible implications for axonal regeneration. J Neurocytol 1995; 24: 1-14
24. Gil J, Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: All for one or one for all. Nat Rev Mol Cell Biol 2006; 7: 667-77
25. Gomez-Sanchez JA, Lopez de Armentia M, Lujan R, Kessaris N, Richardson WD, Cabedo H. Sustained axon-glial signaling induces Schwann cell hyperproliferation, Remak bundle myelination, and tumorigenesis. J Neurosci 2009; 29: 11304-15
26. Gorgoulis VG, Halazonetis TD. Oncogene-induced senescence: The bright and dark side of the response. Curr Opin Cell Biol 2010; 22: 816-27
27. Guertin AD, Zhang DP, Mak KS, Alberta JA, Kim HA. Microanatomy of axon/glial signaling during Wallerian degeneration. J Neurosci 2005; 25: 3478-87
28. Harrisingh MC, Perez-Nadales E, Parkinson DB, Malcolm DS, Mudge AW, Lloyd AC. The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation. EMBO J 2004; 23: 3061-71
29. Jang SW, LeBlanc SE, Roopra A, Wrabetz L, Svaren J. In vivo detection of Egr2 binding to target genes during peripheral nerve myelination. J Neurochem 2006; 98: 1678-87
30. Jessen KR, Mirsky R. The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci 2005; 6: 671-82
31. Jessen KR, Mirsky R. Negative regulation of myelination: Relevance for development, injury, and demyelinating disease. Glia 2008; 56: 1552-65
32. Kim HA, Pomeroy SL, Whoriskey W, Pawlitzky I, Benowitz LI, Sicinski P, et al. A developmentally regulated switch directs regenerative growth of Schwann cells through cyclin D1. Neuron 2000; 26: 405-16
33. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS. The essence of senescence. Genes Dev 2010; 24: 2463-79
34. Le N, Nagarajan R, Wang JY, Araki T, Schmidt RE, Milbrandt J. Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc Natl Acad Sci USA 2005; 102: 2596-601
35. Levi AD, Bunge RP, Lofgren JA, Meima L, Hefti F, Nikolics K, et al. The influence of heregulins on human Schwann cell proliferation. J Neurosci 1995; 15: 1329-40
36. Matheu A, Maraver A, Serrano M. The Arf/p53 pathway in cancer and aging. Cancer Res 2008; 68: 6031-4
37. McClatchey AI. Neurofibromatosis. Annu Rev Pathol 2007; 2: 191-216
38. Monje PV, Soto J, Bacallao K, Wood PM. Schwann cell dedifferentiation is independent of mitogenic signaling and uncoupled to proliferation: Role of cAMP and JNK in the maintenance of the differentiated state. J Biol Chem 2010; 285: 31024-36
39. Napoli I, Noon LA, Ribeiro S, Kerai AP, Parrinello S, Rosenberg LH, et al. A central role for the erk-signaling pathway in controlling schwann cell plasticity and peripheral nerve regeneration in vivo. Neuron 2012; 73: 729-42
40. Pantoja C, Serrano M. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene 1999; 18: 4974-82
41. Parkinson DB, Bhaskaran A, Arthur-Farraj P, Noon LA, Woodhoo A, Lloyd AC, et al. c-Jun is a negative regulator of myelination. J Cell Biol 2008; 181: 625-37
42. Parrinello S, Lloyd AC. Neurofibroma development in NF1-insights into tumour initiation. Trends Cell Biol 2009; 19: 395-403
43. Riccardi VM. Cutaneous manifestation of neurofibromatosis: Cellular interaction, pigmentation, and mast cells. Birth Defects Orig Artic Ser 1981; 17: 129-45
44. Ridley AJ, Davis JB, Stroobant P, Land H. Transforming growth factorsbeta 1 and beta 2 are mitogens for rat Schwann cells. J Cell Biol 1989; 109(6 Pt 2): 3419-3424
45. Rosenbaum C, Karyala S, Marchionni MA, Kim HA, Krasnoselsky AL, Happel B, et al. Schwann cells express NDF and SMDF/n-ARIA mRNAs, secrete neuregulin, and show constitutive activation of erbB3 receptors: Evidence for a neuregulin autocrine loop. Exp Neurol 1997; 148: 604-15
46. Salzer JL, Bunge RP. Studies of Schwann cell proliferation. I. An analysis in tissue culture of proliferation during development, Wallerian degeneration, and direct injury. J Cell Biol 1980; 84: 739-52
47. Salzer JL, Bunge RP, Glaser L. Studies of Schwann cell proliferation. III. Evidence for the surface localization of the neurite mitogen. J Cell Biol 1980; 84: 767-78
48. Scherer SS, Wang DY, Kuhn R, Lemke G, Wrabetz L, Kamholz J. Axons regulate Schwann cell expression of the POU transcription factor SCIP. J Neurosci 1994; 14: 1930-42
49. Sherman DL, Brophy PJ. Mechanisms of axon ensheathment and myelin growth. Nat Rev Neurosci 2005; 6: 683-90
50. Shibuya M, Komi E, Wang R, Kato T, Watanabe Y, Sakai M, et al. Measurement and comparison of serum neuregulin 1 immunoreactivity in control subjects and patients with schizophrenia: An influence of its genetic polymorphism. J Neural Transm 2010; 117: 887-95
51. Shy ME, Shi Y, Wrabetz L, Kamholz J, Scherer SS. Axon-Schwann cell interactions regulate the expression of c-jun in Schwann cells. J Neurosci Res 1996; 43: 511-25
52. Vogel KS, Klesse LJ, Velasco-Miguel S, Meyers K, Rushing EJ, Parada LF. Mouse tumor model for neurofibromatosis type 1. Science 1999; 286: 2176-9
53. Yang C, Klein EA, Assoian RK, Kazanietz MG. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-Dependent induction of cyclin D1 and p21Cip1. Biochem J 2008; 410: 167-75